Finding Patterns In Clinical Study Experiences of Multiple Sclerosis Patients
NCT05503524 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2024-01-02
Summary
Participation in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.
This study will admit a wide range of data on the clinical trial experience of Multiple Sclerosis patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Multiple Sclerosis patients.
Conditions
Sponsors & Collaborators
-
Power Life Sciences Inc.
lead INDUSTRY
Principal Investigators
-
Michael B Gill · Power Life Sciences Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-30
- Primary Completion
- 2025-09-30
- Completion
- 2026-09-30
More Related Trials
-
Therapeutic Adherence of Multiple Sclerosis Patients
NCT04837352 ·Status: RECRUITING
-
A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)
NCT00239655 ·Status: TERMINATED ·Phase: PHASE2
-
Progression of Cognitive and Physical Symptoms in Multiple Sclerosis
NCT00922831 ·Status: WITHDRAWN
-
An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment
NCT06675955 ·Status: RECRUITING ·Phase: PHASE3
-
Complementary and Alternative Care in Multiple Sclerosis
NCT01703429 ·Status: RECRUITING
-
Mesenchymal Stem Cells for Multiple Sclerosis
NCT01730547 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cortical Inhibition in Patients With Multiple Sclerosis
NCT07128160 ·Status: NOT_YET_RECRUITING
-
A Multi-center, Multi-regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without Treatment
NCT00702065 ·Status: COMPLETED
-
Reinventing Yourself With Multiple Sclerosis (MS)
NCT05195320 ·Status: UNKNOWN ·Phase: NA
-
Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis
NCT02326935 ·Status: TERMINATED ·Phase: PHASE1
-
A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis
NCT01737372 ·Status: COMPLETED
-
Relationship Between the Nutritional Habits and Relapsing and Disability Rates in Patient With Multiple Sclerosis.
NCT04110171 ·Status: UNKNOWN
-
Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis
NCT00223457 ·Status: COMPLETED
-
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
NCT00001248 ·Status: RECRUITING
-
Evaluating Intervention Responsiveness in People With Multiple Sclerosis
NCT01632293 ·Status: COMPLETED ·Phase: NA
-
Exercise Booster Sessions in People With Multiple Sclerosis
NCT04913012 ·Status: COMPLETED ·Phase: NA
-
Effects of Resistance Training in Multiple Sclerosis: a Randomized Trial.
NCT06478784 ·Status: RECRUITING ·Phase: NA
-
The MS-LINK™ Outcomes Study
NCT04735406 ·Status: COMPLETED
-
Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS
NCT00813969 ·Status: COMPLETED ·Phase: PHASE1
-
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
NCT05663853 ·Status: COMPLETED
-
Ocrelizumab Effects on Physiological and Cognitive Changes in Multiple Sclerosis
NCT03025269 ·Status: COMPLETED
-
A Single-blinded, Controlled, Multi-centre Study of Effects of Exercise in Participants With Multiple Sclerosis
NCT01065090 ·Status: COMPLETED
-
To Study the Pathophysiological Features of Multiple Sclerosis
NCT04242056 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Pilot and Feasibility Trial of a Telehealth Dietary Intervention for MS
NCT03372187 ·Status: COMPLETED ·Phase: NA
-
Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis
NCT06592703 ·Status: RECRUITING ·Phase: PHASE1